Status:
UNKNOWN
Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men
Lead Sponsor:
Southern California Institute for Research and Education
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Anal Cancer
HIV Infections
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This study will investigate the efficacy and safety of the quadrivalent vaccine (Gardasil) against the human papilloma virus (HPV) in HIV (human immunodeficiency virus) infected males.
Detailed Description
This is a prospective pilot study that will attempt to enroll approximately 150-200 HIV-infected males followed regularly in the ID Primary Care Clinic at the VA Long Beach Healthcare System. All cons...
Eligibility Criteria
Inclusion
- Male veterans
- Age 18 or older
- HIV-positive
- Seen regularly in the ID Primary Care Clinic at the VA Long Beach Healthcare System
Exclusion
- None
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2012
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00666107
Start Date
June 1 2008
End Date
June 1 2012
Last Update
March 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Long Beach Healthcare System
Long Beach, California, United States, 90822-5201